Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloproteinases

L L Johnson1, R Dyer, D J Hupe

  • 1Department of Biochemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA. Linda.Johnson@wl.com

Current Opinion in Chemical Biology
|September 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicentre cross-sectional descriptive study evaluating the cardiovascular risk profile of preoperatively identified patients with hypertension.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Cost benefit analysis of automatic lameness detection systems in dairy herds: A dynamic programming approach.

Preventive veterinary medicine·2020
Same author

Blood pressure measurement in pregnancy.

International journal of obstetric anesthesia·2018
Same author

Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene.

BMJ global health·2017
Same author

Point-of-Care Clinical Ultrasound for Medical Students.

Ultrasound international open·2016
Same author

(13) C mannitol as a novel biomarker for measurement of intestinal permeability.

Neurogastroenterology and motility·2016
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
Same journal

Chemigenetic fluorescent biosensors in biological imaging - New trends and advances.

Current opinion in chemical biology·2026
See all related articles

Matrix metalloproteinases (MMPs) are key enzymes in tissue remodeling. Recent advances in knockout models and selective inhibitors offer new ways to study and treat MMP-related diseases like cancer and arthritis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs) are crucial peptidases regulating extracellular matrix degradation during tissue remodeling.
  • Dysregulated MMP activity is linked to diseases such as cancer and arthritis.
  • Emerging research connects MMPs to an expanding range of pathologies.

Purpose of the Study:

  • To highlight recent advancements in understanding matrix metalloproteinases.
  • To discuss new tools for assessing MMP activity in disease models.
  • To review the progress of MMP inhibitors in clinical trials.

Main Methods:

  • Development of new transgenic models for matrix metalloproteinase knockouts.
  • Clinical trials evaluating selective MMP inhibitors with improved pharmacokinetic profiles.

Related Experiment Videos

Main Results:

  • Transgenic models enable direct assessment of specific MMP activity in disease contexts.
  • Selective MMP inhibitors are progressing through clinical trials, allowing safety and efficacy evaluations.

Conclusions:

  • New research tools and therapeutic strategies are advancing the study of matrix metalloproteinases.
  • Targeting MMPs holds promise for treating a growing list of associated diseases.